Goal of a “Good Death” in End-of-Life Care for Patients with Hematologic Malignancies—Are We Close? Thomas M. KuczmarskiOreofe O. Odejide Health Economics (N Khera, Section Editor) 16 April 2021 Pages: 117 - 125
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery Tamara P. MillerRichard Aplenc Topical Collection on Health Economics (N Khera, Section Editor) 30 March 2021 Pages: 126 - 131
The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond Rahul BanerjeeAmar H. KelkarNaveen Pemmaraju Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor) 31 March 2021 Pages: 132 - 139
Enteropathy-Associated T cell Lymphoma Zakiah Al SomaliMehdi HamadaniMahmoud Aljurf T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor) 19 May 2021 Pages: 140 - 147
Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma Naimisha MarneniRajshekhar Chakraborty Multiple Myeloma (P Kapoor, Section Editor) 19 April 2021 Pages: 148 - 161
MRD Assessment in Multiple Myeloma: Progress and Challenges Luca BertaminiMattia D’AgostinoFrancesca Gay Multiple Myeloma (P Kapoor, Section Editor) 05 May 2021 Pages: 162 - 171
Progress in the Management of Smoldering Multiple Myeloma Timothy M. SchmidtNatalie S. Callander Multiple Myeloma (P Kapoor, Section Editor) 13 May 2021 Pages: 172 - 182
Antibody-Based Treatment Approaches in Multiple Myeloma Hitomi HosoyaSurbhi Sidana Multiple Myeloma (P Kapoor, Section Editor) 17 March 2021 Pages: 183 - 191
Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches Nicole R. GrieselhuberAlice S. Mims Acute Myeloid Leukemias (U Borate, Section Editor) 18 March 2021 Pages: 192 - 206
IDH Inhibitors in AML—Promise and Pitfalls Hannah McMurryLuke FletcherElie Traer Acute Myeloid Leukemias (U Borate, Section Editor) 30 April 2021 Pages: 207 - 217
Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job Melanie SchwerdtfegerMohamed-Reda BenmebarekSebastian Kobold CART and immunotherapy (M Ruella and P Hanley, Section Editors) Open access 30 April 2021 Pages: 218 - 233